Cargando…
Corrigendum: STAM Prolongs Clear Cell Renal Cell Carcinoma Patients’ Survival via Inhibiting Cell Growth and Invasion
Autores principales: | Deng, Tuo, He, Zihao, Duan, Xiaolu, Gu, Di, Cai, Chao, Wu, Wenqi, Liu, Yongda, Zeng, Guohua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8456332/ https://www.ncbi.nlm.nih.gov/pubmed/34568056 http://dx.doi.org/10.3389/fonc.2021.726290 |
Ejemplares similares
-
STAM Prolongs Clear Cell Renal Cell Carcinoma Patients' Survival via Inhibiting Cell Growth and Invasion
por: Deng, Tuo, et al.
Publicado: (2021) -
Profiles of overall survival-related gene expression-based risk signature and their prognostic implications in clear cell renal cell carcinoma
por: He, Zihao, et al.
Publicado: (2020) -
m(6)A modification patterns and tumor immune landscape in clear cell renal carcinoma
por: Zhong, Jiehui, et al.
Publicado: (2021) -
[Corrigendum] miR‑195 inhibits cell proliferation and angiogenesis in human prostate cancer by downregulating PRR11 expression
por: Cai, Chao, et al.
Publicado: (2023) -
The value of cytoreductive nephrectomy on the survival of metastatic renal carcinoma patients based on the number of site-specific metastases
por: Zhao, Zhijian, et al.
Publicado: (2019)